Akero Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Akero Therapeutics, Inc. has filed 734 SEC EDGAR filings since 18 Dec 2018

SEC filing history

Showing 251-275 of 734 matching filings.

Per page
25
Current page
11
4

4

Filing date
11 Jun 2024
Reporting date
08 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
11 Jun 2024
Reporting date
08 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
11 Jun 2024
Reporting date
08 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
11 Jun 2024
Reporting date
08 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
11 Jun 2024
Reporting date
08 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
11 Jun 2024
Reporting date
08 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
11 Jun 2024
Reporting date
08 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91047

JANUS HENDERSON OWNS 10.1%

Filing date
10 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Jun 2024
Reporting date
03 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3ASR File 333-279338

S-3ASR

Filing date
10 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
02 May 2024
Reporting date
01 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
01 May 2024
Reporting date
29 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
01 May 2024
Reporting date
29 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-38944

ARS

Filing date
26 Apr 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38944

DEF 14A

Filing date
26 Apr 2024
Reporting date
07 Jun 2024
Next action
Verify source filing
PRE 14A File 001-38944

PRE 14A

Filing date
16 Apr 2024
Reporting date
07 Jun 2024
Next action
Verify source filing
4

4

Filing date
03 Apr 2024
Reporting date
01 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38944

144 filing

Filing date
01 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
15 Mar 2024
Reporting date
13 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
15 Mar 2024
Reporting date
13 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
15 Mar 2024
Reporting date
13 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .